Palasis Maria (CIK 1810701) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-03). Recent activity: Sell LYRA (2,000 shares), Buy BBNX (3,997 shares), Sell LYRA (1,702 shares), Sell BBNX (906 shares), Sell BBNX (500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | Lyra Therapeutics, Inc. (LYRA) | Principal Executive Officer | Sell | 2,000 | $0 |
| 2026-01-14 | Beta Bionics, Inc. (BBNX) | Director | Buy | 3,997 | $0 |
| 2026-01-08 | Lyra Therapeutics, Inc. (LYRA) | President & CEO | Sell | 1,702 | $5,719 |
| 2025-12-02 | Beta Bionics, Inc. (BBNX) | Director | Sell | 906 | $26,573 |
| 2025-12-02 | Beta Bionics, Inc. (BBNX) | Director | Sell | 500 | $14,980 |
| 2025-11-05 | Beta Bionics, Inc. (BBNX) | Director | Sell | 1,287 | $34,569 |
| 2025-11-05 | Beta Bionics, Inc. (BBNX) | Director | Sell | 119 | $3,267 |
| 2025-07-14 | Lyra Therapeutics, Inc. (LYRA) | President & CEO | Sell | 1,565 | $13,944 |
| 2025-03-18 | Beta Bionics, Inc. (BBNX) | Director | Buy | 11,247 | $0 |
Source: SEC Form 4 filings · as of 2026-04-03